Neumora Therapeutics is trading 10.07% up at $1.53, with no clearly identified company-specific announcement on August 31, 2026.
- The latest official release was its August 14 second-quarter update; its investor-relations page lists no newer press release.
- The broader market is mixed, with major indexes near flat and risk sentiment pressured by rates and geopolitical concerns.
- The move may reflect trading-specific activity or speculative biotech interest.